Literature DB >> 14636960

Neuroadaptive mechanisms of addiction: studies on the extended amygdala.

George F Koob1.   

Abstract

A conceptual structure for drug addiction focused on allostatic changes in reward function that lead to excessive drug intake provides a heuristic framework with which to identify the neurobiologic neuroadaptive mechanisms involved in the development of drug addiction. The brain reward system implicated in the development of addiction is comprised of key elements of a basal forebrain macrostructure termed the extended amygdala and its connections. Neuropharmacologic studies in animal models of addiction have provided evidence for the dysregulation of specific neurochemical mechanisms not only in specific brain reward circuits (opioid peptides, gamma-aminobutyric acid, glutamate and dopamine) but also recruitment of brain stress systems (corticotropin-releasing factor) that provide the negative motivational state that drives addiction, and also are localized in the extended amygdala. The changes in the reward and stress systems are hypothesized to maintain hedonic stability in an allostatic state, as opposed to a homeostatic state, and as such convey the vulnerability for development of dependence and relapse in addiction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636960     DOI: 10.1016/j.euroneuro.2003.08.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  114 in total

1.  Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.

Authors:  Anna Castañé; Rafael Maldonado; Olga Valverde
Journal:  Br J Pharmacol       Date:  2004-07-20       Impact factor: 8.739

2.  Amygdala 14-3-3ζ as a novel modulator of escalating alcohol intake in mice.

Authors:  Heidi M B Lesscher; Julia M Houthuijzen; Marian J Groot Koerkamp; Frank C P Holstege; Louk J M J Vanderschuren
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

3.  The Neurobiology of Addiction: Where We Have Been and Where We Are Going.

Authors:  George F Koob; Eric J Simon
Journal:  J Drug Issues       Date:  2009-01

4.  Enhanced dendritic availability of μ-opioid receptors in inhibitory neurons of the extended amygdala in mice deficient in the corticotropin-releasing factor-1 receptor.

Authors:  Azra Jaferi; Ping Zhou; Virginia M Pickel
Journal:  Synapse       Date:  2011-01       Impact factor: 2.562

Review 5.  Stress, dysregulation of drug reward pathways, and the transition to drug dependence.

Authors:  George Koob; Mary Jeanne Kreek
Journal:  Am J Psychiatry       Date:  2007-08       Impact factor: 18.112

6.  Effect of sustained-release (SR) bupropion on craving and withdrawal in smokers deprived of cigarettes for 72 h.

Authors:  Vincenzo Teneggi; Stephen T Tiffany; Lisa Squassante; Stefano Milleri; Luigi Ziviani; Alan Bye
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

7.  The effects of medial prefrontal cortex infusions of cocaine in a runway model of drug self-administration: evidence of reinforcing but not anxiogenic actions.

Authors:  Daniel Guzman; Justin M Moscarello; Aaron Ettenberg
Journal:  Eur J Pharmacol       Date:  2009-01-10       Impact factor: 4.432

Review 8.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 9.  Amygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann Kelley.

Authors:  Eric P Zorrilla; George F Koob
Journal:  Neurosci Biobehav Rev       Date:  2012-12-07       Impact factor: 8.989

10.  Alcohol attenuates amygdala-frontal connectivity during processing social signals in heavy social drinkers: a preliminary pharmaco-fMRI study.

Authors:  Stephanie M Gorka; Daniel A Fitzgerald; Andrea C King; K Luan Phan
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.